Genetic covariance between γ-glutamyl transpeptidase and fatty liver risk factors: Role of β2-adrenergic receptor genetic variation in twins

Gastroenterology

Volumn 139, Issue 3, 2010, Pages

  Loomba, Rohit ^a   Rao, Fangwen ^a   Zhang, Lian ^a   Khandrika, Srikrishna ^a   Ziegler, Michael G ^a   Brenner, David A ^a   O'Connor, Daniel T ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

ADRB2; GGT; Metabolic Syndrome; NAFLD

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; GAMMA GLUTAMYLTRANSFERASE; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; URIC ACID; BIOLOGICAL MARKER; LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; BLOOD LEVEL; COVARIANCE; DIASTOLIC BLOOD PRESSURE; ENZYME ACTIVITY; FEMALE; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HERITABILITY; HUMAN; HYPERTENSION; INSULIN RESISTANCE; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; OBESITY; PHENOTYPE; PLEIOTROPY; PRIORITY JOURNAL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; TRIACYLGLYCEROL BLOOD LEVEL; TWINS; BLOOD; BLOOD PRESSURE; CROSS-SECTIONAL STUDY; DYSLIPIDEMIA; ENZYMOLOGY; FATTY LIVER; GENETIC PREDISPOSITION; GENETICS; HEREDITY; METABOLIC SYNDROME X; MIDDLE AGED; PATHOPHYSIOLOGY; QUANTITATIVE TRAIT; RISK ASSESSMENT; UNITED STATES; UPREGULATION;

ADULT; BIOLOGICAL MARKERS; BLOOD PRESSURE; CALIFORNIA; CROSS-SECTIONAL STUDIES; DYSLIPIDEMIAS; FATTY LIVER; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HEREDITY; HUMANS; HYPERTENSION; INSULIN RESISTANCE; LIPOPROTEINS, LDL; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; QUANTITATIVE TRAIT, HERITABLE; RECEPTORS, ADRENERGIC, BETA-2; RISK ASSESSMENT; RISK FACTORS; TRIGLYCERIDES; TWINS; UP-REGULATION; URIC ACID;

EID: 84925581279     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2010.06.009     Document Type: Article

References (60)

1. A.M. Ruttenburg, J.A. Goldbarg, and E.P. Pineda Serum gamma-glutamyl transpeptidase activity in hepatobiliary pancreatic disease Gastroenterology 45 1963 43 48
2. E. Nemesanszky, and J.A. Lott Gamma-glutamyltransferase and its isoenzymes: progress and problems Clin Chem 31 1985 797 803
3. M. Irie, N. Suzuki, and T. Sohda Hepatic expression of gamma-glutamyltranspeptidase in the human liver of patients with alcoholic liver disease Hepatol Res 37 2007 966 973
4. J.B. Whitfield Gamma glutamyl transferase Crit Rev Clin Lab Sci 38 2001 263 355
5. E. Ikai, R. Honda, and Y. Yamada Serum gamma-glutamyl transpeptidase level and blood pressure in nondrinkers: a possible pathogenetic role of fatty liver in obesity-related hypertension J Hum Hypertens 8 1994 95 100
6. E. Ikai, Y. Noborizaka, I. Tsuritani, R. Honda, M. Ishizaki, and Y. Yamada Serum gamma-glutamyl transpeptidase levels and hypertension in non-drinkers: a possible role of fatty liver in the pathogenesis of obesity related hypertension Obes Res 1 1993 469 474
7. D.S. Lee, J.C. Evans, and S.J. Robins Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk: the Framingham Heart Study Arterioscler Thromb Vasc Biol 27 2007 127 133
8. S.K. Jo, W.Y. Lee, and E.J. Rhee Serum gamma-glutamyl transferase activity predicts future development of metabolic syndrome defined by 2 different criteria Clin Chim Acta 403 2009 234 240
9. S.K. Jo, W.Y. Lee, and E.J. Rhee Serum gamma-glutamyl transferase activity predicts future development of metabolic syndrome defined by 2 different criteria Clin Chim Acta 403 12 2009 234 240
10. J.B. Dixon, P.S. Bhathal, and P.E. O'Brien Weight loss and non-alcoholic fatty liver disease: falls in gamma-glutamyl transferase concentrations are associated with histologic improvement Obes Surg 16 2006 1278 1286
11. D.H. Lee, D.R. Jacobs Jr, and M. Gross Gamma-glutamyltransferase is a predictor of incident diabetes and hypertension: the Coronary Artery Risk Development in Young Adults (CARDIA) Study Clin Chem 49 2003 1358 1366
12. C.H. Saely, A. Vonbank, and P. Rein Alanine aminotransferase and gamma-glutamyl transferase are associated with the metabolic syndrome but not with angiographically determined coronary atherosclerosis Clin Chim Acta 397 2008 82 86
13. J. Yamada, H. Tomiyama, and M. Yambe Elevated serum levels of alanine aminotransferase and gamma glutamyltransferase are markers of inflammation and oxidative stress independent of the metabolic syndrome Atherosclerosis 189 2006 198 205
14. F. Rao, L. Zhang, and J. Wessel Tyrosine hydroxylase, the rate-limiting enzyme in catecholamine biosynthesis: discovery of common human genetic variants governing transcription, autonomic activity, and blood pressure in vivo Circulation 116 2007 993 1006
15. J. Wessel, G. Moratorio, and F. Rao C-reactive protein, an 'intermediate phenotype' for inflammation: human twin studies reveal heritability, association with blood pressure and the metabolic syndrome, and the influence of common polymorphism at catecholaminergic/beta-adrenergic pathway loci J Hypertens 25 2007 329 343
16. X. Bao, P.J. Mills, and B.K. Rana Interactive effects of common beta2-adrenoceptor haplotypes and age on susceptibility to hypertension and receptor function Hypertension 46 2005 301 307
17. N. Iwamoto, Y. Ogawa, and S. Kajihara Gln27Glu beta2-adrenergic receptor variant is associated with hypertriglyceridemia and the development of fatty liver Clin Chim Acta 314 2001 85 91
18. O. Vardeny, M.A. Detry, J.J. Moran, M.R. Johnson, and N.K. Sweitzer The beta2 adrenergic receptor Gln27Glu polymorphism affects insulin resistance in patients with heart failure: possible modulation by choice of beta blocker J Cardiovasc Pharmacol 52 2008 500 506
19. C.A. Isaza, J. Henao, J.C. Sanchez, G.L. Porras, J. Cardona, and G. Bedoya Beta-2-adrenergic receptor polymorphisms and changes in lipids induced by metoprolol Pharmacology 80 2007 279 285
20. L.P. Svetkey, P.Z. Timmons, O. Emovon, N.B. Anderson, L. Preis, and Y.T. Chen Association of hypertension with beta2- and alpha2c10-adrenergic receptor genotype Hypertension 27 1996 1210 1215
21. H.M. Patton, J.E. Lavine, M.L. Van Natta, J.B. Schwimmer, D. Kleiner, and J. Molleston Clinical correlates of histopathology in pediatric nonalcoholic steatohepatitis Gastroenterology 135 2008 1961 1971 e1962
22. E. von Elm, D.G. Altman, M. Egger, S.J. Pocock, P.C. Gotzsche, and J.P. Vandenbroucke The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies Ann Intern Med 147 2007 573 577
23. L. Zhang, F. Rao, and K. Zhang Discovery of common human genetic variants of GTP cyclohydrolase 1 (GCH1) governing nitric oxide, autonomic activity, and cardiovascular risk J Clin Invest 117 2007 2658 2671
24. L. Zhang, F. Rao, and J. Wessel Functional allelic heterogeneity and pleiotropy of a repeat polymorphism in tyrosine hydroxylase: prediction of catecholamines and response to stress in twins Physiol Genomics 19 2004 277 291
25. T.J. Brinton, M.T. Kailasam, and R.A. Wu Arterial compliance by cuff sphygmomanometer Application to hypertension and early changes in subjects at genetic risk Hypertension 28 1996 599 603
26. C.M. Drysdale, D.W. McGraw, and C.B. Stack Complex promoter and coding region beta 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness Proc Natl Acad Sci U S A 97 2000 10483 10488
27. D.W. McGraw, S.L. Forbes, L.A. Kramer, and S.B. Liggett Polymorphisms of the 5' leader cistron of the human beta2-adrenergic receptor regulate receptor expression J Clin Invest 102 1998 1927 1932
28. K.H. Buetow, M. Edmonson, and R. MacDonald High-throughput development and characterization of a genomewide collection of gene-based single nucleotide polymorphism markers by chip-based matrix-assisted laser desorption/ionization time-of-flight mass spectrometry Proc Natl Acad Sci U S A 98 2001 581 584
29. J.A. Goldbarg, E.P. Pineda, E.E. Smith, O.M. Friedman, and A.M. Rutenburg A method for the colorimetric determination of gamma-glutamyl transpeptidase in human serum; enzymatic activity in health and disease Gastroenterology 44 1963 127 133
30. E. Halperin, and E. Eskin Haplotype reconstruction from genotype data using Imperfect Phylogeny Bioinformatics 20 2004 1842 1849
31. J.C. Barrett, B. Fry, J. Maller, and M.J. Daly Haploview: analysis and visualization of LD and haplotype maps Bioinformatics 21 2005 263 265
32. S.E. Johnatty, M. Abdellatif, L. Shimmin, R.B. Clark, and E. Boerwinkle Beta 2 adrenergic receptor 5' haplotypes influence promoter activity Br J Pharmacol 137 2002 1213 1216
33. D.E. Lanfear, P.G. Jones, S. Marsh, S. Cresci, H.L. McLeod, and J.A. Spertus Beta2-adrenergic receptor genotype and survival among patients receiving beta-blocker therapy after an acute coronary syndrome JAMA 294 2005 1526 1533
34. K.M. Small, D.W. McGraw, and S.B. Liggett Pharmacology and physiology of human adrenergic receptor polymorphisms Annu Rev Pharmacol Toxicol 43 2003 381 411
35. J.A. Oben, S. Yang, H. Lin, M. Ono, and A.M. Diehl Norepinephrine and neuropeptide Y promote proliferation and collagen gene expression of hepatic myofibroblastic stellate cells Biochem Biophys Res Commun 302 2003 685 690
36. J.A. Oben, T. Roskams, and S. Yang Hepatic fibrogenesis requires sympathetic neurotransmitters Gut 53 2004 438 445
37. J.A. Oben, T. Roskams, and S. Yang Norepinephrine induces hepatic fibrogenesis in leptin deficient ob/ob mice Biochem Biophys Res Commun 308 2003 284 292
38. M.G. O'Riordain, J.A. Ross, and K.C. Fearon Insulin and counterregulatory hormones influence acute-phase protein production in human hepatocytes Am J Physiol 269 1995 E323 E330
39. Z. Li, J.A. Oben, and S. Yang Norepinephrine regulates hepatic innate immune system in leptin-deficient mice with nonalcoholic steatohepatitis Hepatology 40 2004 434 441
40. J.A. Oben, T. Roskams, and S. Yang Sympathetic nervous system inhibition increases hepatic progenitors and reduces liver injury Hepatology 38 2003 664 673
41. J.C. Van Heeswijk, G.J. Vianen, and G.E. van den Thillart The adrenergic control of hepatic glucose and FFA metabolism in rainbow trout (Oncorhynchus mykiss): increased sensitivity to adrenergic stimulation with fasting Gen Comp Endocrinol 145 2006 51 61
42. D.M. Hargrove, G.J. Bagby, C.H. Lang, and J.J. Spitzer Adrenergic blockade prevents endotoxin-induced increases in glucose metabolism Am J Physiol 255 1988 E629 E635
43. National Health and Nutrition Examiniation Survey 1999-2002 http://www.cdc.gov/nchs/nhanes.htm Accessed August 4, 2010
44. J.B. Whitfield, G. Zhu, J.E. Nestler, A.C. Heath, and N.G. Martin Genetic covariation between serum gamma-glutamyltransferase activity and cardiovascular risk factors Clin Chem 48 2002 1426 1431
45. N. Rahmioglu, T. Andrew, and L. Cherkas Epidemiology and genetic epidemiology of the liver function test proteins PLoS ONE 4 2009 e4435
46. J.P. Lin, C.J. O'Donnell, C.S. Fox, and L.A. Cupples Heritability of serum gamma-glutamyltransferase level: genetic analysis from the Framingham Offspring Study Liver Int 29 2009 776 777
47. X. Yuan, D. Waterworth, and J.R. Perry Population-based genome-wide association studies reveal six loci influencing plasma levels of liver enzymes Am J Hum Genet 83 2008 520 528
48. L. Bathum, H.C. Petersen, J.U. Rosholm, P. Hyltoft Petersen, J. Vaupel, and K. Christensen Evidence for a substantial genetic influence on biochemical liver function tests: results from a population-based Danish twin study Clin Chem 47 2001 81 87
49. A. Valle, D.T. O'Connor, and P. Taylor Butyrylcholinesterase: association with the metabolic syndrome and identification of 2 gene loci affecting activity Clin Chem 52 2006 1014 1020
50. S. Romeo, J. Kozlitina, and C. Xing Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease Nat Genet 40 2008 1461 1465
51. P.A. Wilson, S.D. Gardner, N.M. Lambie, S.A. Commans, and D.J. Crowther Characterization of the human patatin-like phospholipase family J Lipid Res 47 2006 1940 1949
52. J.W. Jocken, D. Langin, and E. Smit Adipose triglyceride lipase and hormone-sensitive lipase protein expression is decreased in the obese insulin-resistant state J Clin Endocrinol Metab 92 2007 2292 2299
53. M. Ryden, J. Jocken, and V. van Harmelen Comparative studies of the role of hormone-sensitive lipase and adipose triglyceride lipase in human fat cell lipolysis Am J Physiol Endocrinol Metab 292 2007 E1847 E1855
54. H. Mulder, M. Sorhede-Winzell, and J.A. Contreras Hormone-sensitive lipase null mice exhibit signs of impaired insulin sensitivity whereas insulin secretion is intact J Biol Chem 278 2003 36380 36388
55. C.P. Day Genes or environment to determine alcoholic liver disease and non-alcoholic fatty liver disease Liver Int 26 2006 1021 1028
56. E.K. Speliotes Genetics of common obesity and nonalcoholic fatty liver disease Gastroenterology 136 2009 1492 1495
57. N.M. Wilfred de Alwis, and C.P. Day Genetics of alcoholic liver disease and nonalcoholic fatty liver disease Semin Liver Dis 27 2007 44 54
58. D. Lebrec, T. Poynard, P. Hillon, and J.P. Benhamou Propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: a controlled study N Engl J Med 305 1981 1371 1374
59. J.P. Pascal, and P. Cales Propranolol in the prevention of first upper gastrointestinal tract hemorrhage in patients with cirrhosis of the liver and esophageal varices N Engl J Med 317 1987 856 861
60. J. Turnes, M. Hernandez-Guerra, and J.G. Abraldes Influence of beta-2 adrenergic receptor gene polymorphism on the hemodynamic response to propranolol in patients with cirrhosis Hepatology 43 2006 34 41